Association between early life antibiotic use and childhood overweight and obesity: a narrative review.

IF 1.1 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Global Health Epidemiology and Genomics Pub Date : 2018-10-24 eCollection Date: 2018-01-01 DOI:10.1017/gheg.2018.16
Uttara Partap, Sophie H Allcock, Edyth Parker, Deepti Gurdasani, Elizabeth H Young, Manjinder S Sandhu
{"title":"Association between early life antibiotic use and childhood overweight and obesity: a narrative review.","authors":"Uttara Partap,&nbsp;Sophie H Allcock,&nbsp;Edyth Parker,&nbsp;Deepti Gurdasani,&nbsp;Elizabeth H Young,&nbsp;Manjinder S Sandhu","doi":"10.1017/gheg.2018.16","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recent research implicates antibiotic use as a potential contributor to child obesity risk. In this narrative review, we examine current observational evidence on the relation between antibiotic use in early childhood and subsequent measures of child body mass.</p><p><strong>Methods: </strong>We searched PubMed, Web of Science and the Cochrane Library to identify studies that assessed antibiotic exposure before 3 years of age and subsequent measures of body mass or risk of overweight or obesity in childhood.</p><p><strong>Results: </strong>We identified 13 studies published before October 2017, based on a total of 6 81 332 individuals, which examined the relation between early life antibiotic exposure and measures of child body mass. Most studies did not appropriately account for confounding by indication for antibiotic use. Overall, we found no consistent and conclusive evidence of associations between early life antibiotic use and later child body mass [minimum overall adjusted odds ratio (aOR) reported: 1.01, 95% confidence interval (95% CI) 0.98-1.04, <i>N</i> = 2 60 556; maximum overall aOR reported: 2.56, 95% CI 1.36-4.79, <i>N</i> = 616], with no clinically meaningful increases in weight reported (maximum increase: 1.50 kg at 15 years of age). Notable methodological differences between studies, including variable measures of association and inclusion of confounders, limited more comprehensive interpretations.</p><p><strong>Conclusions: </strong>Evidence to date is insufficient to indicate that antibiotic use is an important risk factor for child obesity, or leads to clinically important differences in weight. Further comparable studies using routine clinical data may help clarify this association.</p>","PeriodicalId":44052,"journal":{"name":"Global Health Epidemiology and Genomics","volume":"3 ","pages":"e18"},"PeriodicalIF":1.1000,"publicationDate":"2018-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1017/gheg.2018.16","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Health Epidemiology and Genomics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/gheg.2018.16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 6

Abstract

Background: Recent research implicates antibiotic use as a potential contributor to child obesity risk. In this narrative review, we examine current observational evidence on the relation between antibiotic use in early childhood and subsequent measures of child body mass.

Methods: We searched PubMed, Web of Science and the Cochrane Library to identify studies that assessed antibiotic exposure before 3 years of age and subsequent measures of body mass or risk of overweight or obesity in childhood.

Results: We identified 13 studies published before October 2017, based on a total of 6 81 332 individuals, which examined the relation between early life antibiotic exposure and measures of child body mass. Most studies did not appropriately account for confounding by indication for antibiotic use. Overall, we found no consistent and conclusive evidence of associations between early life antibiotic use and later child body mass [minimum overall adjusted odds ratio (aOR) reported: 1.01, 95% confidence interval (95% CI) 0.98-1.04, N = 2 60 556; maximum overall aOR reported: 2.56, 95% CI 1.36-4.79, N = 616], with no clinically meaningful increases in weight reported (maximum increase: 1.50 kg at 15 years of age). Notable methodological differences between studies, including variable measures of association and inclusion of confounders, limited more comprehensive interpretations.

Conclusions: Evidence to date is insufficient to indicate that antibiotic use is an important risk factor for child obesity, or leads to clinically important differences in weight. Further comparable studies using routine clinical data may help clarify this association.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
生命早期抗生素使用与儿童超重和肥胖之间的关系:一项叙述性综述。
背景:最近的研究表明抗生素的使用是儿童肥胖风险的潜在因素。在这篇叙述性综述中,我们研究了目前关于儿童早期抗生素使用与随后儿童体重测量之间关系的观察证据。方法:我们检索了PubMed, Web of Science和Cochrane Library,以确定评估3岁前抗生素暴露和随后的体重测量或儿童超重或肥胖风险的研究。结果:我们确定了2017年10月之前发表的13项研究,这些研究基于总共681 332名个体,研究了生命早期抗生素暴露与儿童体重测量之间的关系。大多数研究没有适当地解释抗生素使用指征的混淆。总体而言,我们没有发现生命早期抗生素使用与后期儿童体重之间存在一致和确凿的证据[报道的最小总体调整优势比(aOR): 1.01, 95%可信区间(95% CI) 0.98-1.04, N = 2 60 556;报告的最大总体aOR: 2.56, 95% CI 1.36-4.79, N = 616],未报告有临床意义的体重增加(15岁时最大增加:1.50 kg)。研究之间显著的方法差异,包括关联的变量测量和混杂因素的纳入,限制了更全面的解释。结论:迄今为止的证据不足以表明抗生素的使用是儿童肥胖的重要危险因素,或导致临床上重要的体重差异。使用常规临床数据的进一步可比研究可能有助于澄清这种关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Global Health Epidemiology and Genomics
Global Health Epidemiology and Genomics PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
1.40
自引率
0.00%
发文量
10
审稿时长
20 weeks
期刊最新文献
Family History of Hypertension and Echocardiographic Left Ventricular Hypertrophy in Hypertensive Nigerians. Magnitude of Neonatal Sepsis and Factors Associated with It among Neonates Admitted to the Intensive Care Units of Neonate in the Primary Hospital of Hawzen, Tigray, Ethiopia, 2020. Shisha Consumption and Presence of Cotinine in Saliva Samples among Students in Public Universities in Coastal Kenya. Regionalization of the Mortality Risk from Cardiomyopathy and Respiratory Diseases Based on the Maximum Entropy Model. Healthcare Providers' Adherence to COVID-19 Prevention and Control Practices in Health Records and Information Management, Ghana.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1